15 results
Summary of dosing recommendations in renal impairment of commonly used hypoglycaemic agents

#Diabetes #Diabetic #Medications #Pharmacology #Dosing
hypoglycaemic agents ... #Diabetes #Diabetic ... #Medications #Pharmacology ... #Dosing #Dosing ... Impairment #CKD #Table
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Non-Opioid Analgesics - Agents ... and Dosing #Management ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... #Table #PAMI
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... #pharmacology #pharmacotherapy ... #table #comparison ... #management #medications
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Muscle Relaxants - Agents ... and Dosing #Management ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Distribution, Agents ... and Dosing Table ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
Assessment and Management ... : Agent, Initiation ... #Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
- Agents and Dosing ... #Management # ... Pain #Pharmacology ... #Doses #Dosing ... #Table #PAMI
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
Diuretics and Agents ... irrigation • Management ... Acute myocardial infarction ... Diuresis #Nephrology #Pharmacology ... #Medications #Table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... drug to remain stable ... #semaglutide #Diabetes ... #Pharmacology #
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
best prevented by using ... ., concomitant medications ... Prevention #Treatment #management ... #opportunistic ... #pharmacology